Janet Lambert, CEO, Alliance for Regenerative Medicine (ARM), Washington, DC, touches on the various barriers that currently challenge the rich and exciting regenerative medicine field. Such challenges include manufacturing, regulatory issues, and the reimbursement models currently in place. This interview took place during the 2020 Meeting on the Mesa congress.